PCA(P)(2025)07 - Community Pharmacy Financial Settlement 2025/26 Reimbursement Arrangements

Published: 01/05/25

Introduction

This circular sets out to community pharmacy contractors and Health Boards the details of the reimbursement arrangements as part of the community pharmacy funding settlement for 2025/26.

Background

Circular PCA(P)(2024) 28 advised on amendments to the remuneration and reimbursement arrangements listed in Part 7 of the Drug Tariff (generics) along with the Part 7 discount clawback rate for the financial year 2024/25.

An agreement has now been reached with Community Pharmacy Scotland on the reimbursement arrangements and changes to the Scottish Drug Tariff for the financial year 2025/26.  Discussions on  community pharmacy remuneration arrangements will be communicated once concluded.

Detail

This circular advises on the reimbursement arrangements as part of the community pharmacy funding package for 2025/26:

• The continued mapping of funding from Part 7 (generic) Drug Tariff as guaranteed income will increase by £20m to £100 million for the financial year. This increase will be allocated to supporting continued service delivery.

Amendments to the Scottish Drug Tariff will be published on the Public Health Scotland website shortly.

In addition, the current level of Guaranteed Minimum Income shall increase by £10m to £120m. The delivery of the Guaranteed Minimum Income will be closely monitored monthly throughout the year and further action to support contractor cashflow will be considered if appropriate.